# AMONDYS 45
> **NDA213026** · New Drug Application · Sponsor: SAREPTA THERAPS INC · Approved 2021-02-25
## Drug
- **FDA Application Number:** NDA213026
- **Application type:** New Drug Application
- **Brand name:** AMONDYS 45
- **Generic name:** CASIMERSEN
- **Active ingredients:** CASIMERSEN
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** SAREPTA THERAPS INC
- **Manufacturer:** Sarepta Therapeutics, Inc.
- **First approval:** 2021-02-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213026)
---
*MORVS · CC0 1.0*